Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Braxton Lagerman"'
Autor:
Mellar Davis, Erin Vanenkevort, Amanda Young, Mark Wojtowicz, Braxton Lagerman, Mudit Gupta, Christian Adonizio, Rajiv Panikkar
Publikováno v:
Journal of Pain and Symptom Management. 65:456-464
Autor:
Timothy C. Shuey, Stephen John Voyce, Alicia Johns, Braxton Lagerman, Alexis Gallagher, Shikhar Agarwal
Publikováno v:
Journal of the American College of Cardiology. 81:1760
Autor:
Timothy C. Shuey, Stephen John Voyce, Alicia Johns, Braxton Lagerman, Alexis Gallagher, Shikhar Agarwal
Publikováno v:
Journal of the American College of Cardiology. 81:1122
Autor:
John M. Pfeifer, Ashraf T. Hafez, Daniel B. Rocha, Christopher W. Good, Arun Nemani, Linyuan Jing, Jeffery A. Ruhl, Nathan J. Stoudt, Kipp W. Johnson, Gargi Schneider, Braxton Lagerman, Alvaro E. Ulloa-Cerna, Tanner Carbonati, Brandon K. Fornwalt, Christoph J. Griessenauer, Christopher M. Haggerty, Dustin N. Hartzel, Sushravya Raghunath, David P. vanMaanen, Noah Zimmerman, Joseph B. Leader, H. Lester Kirchner
Publikováno v:
Circulation
Supplemental Digital Content is available in the text.
Background: Atrial fibrillation (AF) is associated with substantial morbidity, especially when it goes undetected. If new-onset AF could be predicted, targeted screening could be used to fin
Background: Atrial fibrillation (AF) is associated with substantial morbidity, especially when it goes undetected. If new-onset AF could be predicted, targeted screening could be used to fin
Autor:
Vladimir Gainullin, Jing Tong, Yali Li, Mudit Gupta, Braxton Lagerman, Jackie Blank, Paul J. Limburg, Christine Hathaway
Publikováno v:
Journal of Clinical Oncology. 40:10526-10526
10526 Background: Cancer screening provides a straightforward diagnostic path compared to non-screening, which often requires complex evaluation for patients with non-specific symptoms. The time to diagnosis (from clinical presentation or screening e
Autor:
Sean J, Jurgens, Seung Hoan, Choi, Valerie N, Morrill, Mark, Chaffin, James P, Pirruccello, Jennifer L, Halford, Lu-Chen, Weng, Victor, Nauffal, Carolina, Roselli, Amelia W, Hall, Matthew T, Oetjens, Braxton, Lagerman, David P, vanMaanen, Krishna G, Aragam, Kathryn L, Lunetta, Christopher M, Haggerty, Steven A, Lubitz, Sarah E, Wolf
Publikováno v:
Nature genetics. 54(3)
Cardiometabolic diseases are the leading cause of death worldwide. Despite a known genetic component, our understanding of these diseases remains incomplete. Here, we analyzed the contribution of rare variants to 57 diseases and 26 cardiometabolic tr
Autor:
Yali Li, Mudit Gupta, Christine Hathaway, Ariella Cohain, John Keilty, Braxton Lagerman, Sam Asgarian, Jackie Blank
Publikováno v:
Journal of Clinical Oncology. 39:10557-10557
10557 Background: Several studies have shown screening methods can detect cancer at earlier stages and improve cancer prognosis; however, only four cancer types (breast, colorectal, cervical, and lung) currently have screening methods recommended by
Autor:
Erin A Vanenkevort, Alex Parker, Claire Jones, Anne Marie O’Broin-Lennon, Rosemary Leeming, Ashley Honushefsky, Mudit Gupta, Adam H. Buchanan, Andrew Warren, Braxton Lagerman, Ariella Cohain
Publikováno v:
Journal of Clinical Oncology. 38:1563-1563
1563 Background: Blood-based tests may enable minimally invasive detection of multiple cancer types. One such test, CancerSEEK, employs ctDNA and protein biomarkers for this purpose. Test performance has been evaluated in women without a history of c